Regarding “Hormone Replacement Therapy Prescription After Premature Surgical Menopause”
With a great deal of interest we read the article entitled ” Hormone Replacement Therapy Prescription After Premature Surgical Menopause” by Garg et al [1]. They analysed a cohort of Sixty-three of which 20.6% had operation for gynaecological cancer including cervical cancer (1.6%), uterine cancer (14.2%), and ovarian cancer (4.8%).Other indications wer e BRCA carrier (17.4%), breast cancer (9.5%), Lynch syndrome (4.8%). Women treated for gynaecological or breast cancer or had BRCA gene mutations were less likely to use HRT.
Source: The Journal of Minimally Invasive Gynecology - Category: OBGYN Authors: Christos Iavazzo, Ioannis Gkegkes Tags: LETTER TO THE EDITOR Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Cancer of the Uterus | Cervical Cancer | Genetics | HNPCC | Hormone Replacement Therapy | Hormones | Lynch Syndrome | Men | OBGYN | Ovarian Cancer | Ovaries | Women